Current diagnosis and management of medullary thyroid carcinoma

This publication has 54 references indexed in Scilit:

• Genetic Testing in Medullary Thyroid Carcinoma Syndromes: Mutation Types and Clinical Significance
  Mayo Clinic Proceedings, 1997
• APPLICATION OF GENETIC SCREENING INFORMATION TO THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2
  Endocrinology and Metabolism Clinics of North America, 1996
• RET Gene and Its Implications for Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Medullary Thyroid Carcinoma: Recent Advances and Management Update
  Thyroid®, 1995
• From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A family*
  Journal of Internal Medicine, 1995
• Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A
  Annals of Surgery, 1994
• Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
  Nature Genetics, 1994
• A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
  Nature, 1994
• Medullary Thyroid Carcinoma: Clinicopathologic Features and Long-Term Follow-Up of 65 Patients Treated During 1946 Through 1970
  Mayo Clinic Proceedings, 1992
• MEDULLARY (SOLID) CARCINOMA OF THE THYROID—A CLINICOPATHOLOGIC ENTITY*
  Journal of Clinical Endocrinology & Metabolism, 1959